Stock GUARD GUARD THERAPEUTICS INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Guard Therapeutics International AB

Equities

GUARD

SE0021181559

Market Closed - Nasdaq Stockholm
Other stock markets
 08:59:59 17/05/2024 pm IST 		5-day change 1st Jan Change
36.8 SEK -4.17% Intraday chart for Guard Therapeutics International AB +11.52% +2.79%
08/05 Guard Therapeutics International AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
15/04 Guard Therapeutics Receives First Regulatory Approval for the Phase 2b Study POINTER CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Guard Therapeutics International AB Appoints Nomination Committee for 2024
CI
Guard Therapeutics presents the Nomination Committee for 2023
AQ
Guard Therapeutics International AB Announces Nomination Committee Appointments
CI
Guard Therapeutics International AB Appoints Torbjörn Larsson as Head of CMC (Chemistry, Manufacturing and Controls), Effective 1 May 2022
CI
Guard Therapeutics Appoints Michael Reusch as Chief Medical Officer, Effective January 1, 2022
CI
Guard Therapeutics appoints Sara Thuresson as Head of Clinical Operations
CI
Guard Therapeutics Appoints Ann-Kristin Myde as Head of Global Project Management, Effective 1 April 2021
CI
Guard Therapeutics Appoints Peter Gilmour as Head of Preclinical Science, Effective 1 August 2020
CI
A1M Pharma AB will Change its Name to Guard Therapeutics International AB
CI
A1M Pharma Appoints Tobias Larsson Agervald as Chief Medical Officer
CI
A1M Pharma Appoints Martin Austin as Business Development Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GUARD Stock
  4. News Guard Therapeutics International AB
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW